These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12652201)

  • 1. Ducking stray "magic bullets": a Melan-A alert.
    Maize JC; Resneck JS; Shapiro PE; McCalmont TH; LeBoit PE
    Am J Dermatopathol; 2003 Apr; 25(2):162-5. PubMed ID: 12652201
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activation of epidermal melanocytes is independent of epithelial proliferation and vascularization. Immunohistologic study using HMB-45 antibody with review of the literature].
    Lommel K; Tronnier M; Wolff HH
    Hautarzt; 1996 Aug; 47(8):616-23. PubMed ID: 8964704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A metastatic melanoma with an unusual immunophenotypic profile.
    Gao Z; Stanek A; Chen S
    Am J Dermatopathol; 2007 Apr; 29(2):169-71. PubMed ID: 17414440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ["Blue" variant of naevus spilus].
    Kiene P; Brodersen JP; Fölster-Holst R
    Hautarzt; 1995 May; 46(5):349-51. PubMed ID: 7607901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant combined squamomelanocytic tumor: a clinical case.
    Wong D; Irimies A; Shkrum M; Joseph MG
    Dermatol Online J; 2013 Sep; 19(9):19610. PubMed ID: 24050285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microphthalmia transcription factor: not a sensitive or specific marker for the diagnosis of desmoplastic melanoma and spindle cell (non-desmoplastic) melanoma.
    Granter SR; Weilbaecher KN; Quigley C; Fletcher CD; Fisher DE
    Am J Dermatopathol; 2001 Jun; 23(3):185-9. PubMed ID: 11391097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melan-A/MART-1 positive "pseudonests" in lichenoid inflammatory lesions: an uncommon phenomenon.
    Demartini CS; Dalton MS; Ferringer T; Elston DM
    Am J Dermatopathol; 2005 Aug; 27(4):370-1. PubMed ID: 16121069
    [No Abstract]   [Full Text] [Related]  

  • 8. The usefulness of tyrosinase in the immunohistochemical assessment of melanocytic lesions: a comparison of the novel T311 antibody (anti-tyrosinase) with S-100, HMB45, and A103 (anti-melan-A).
    Clarkson KS; Sturdgess IC; Molyneux AJ
    J Clin Pathol; 2001 Mar; 54(3):196-200. PubMed ID: 11253130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S100, HMB-45, and Melan-A negative primary melanoma.
    Shinohara MM; Deubner H; Argenyi ZB
    Dermatol Online J; 2009 Sep; 15(9):7. PubMed ID: 19930994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology].
    Monti M; Berti E; Cavicchini S; Paindelli MG; Terragni L
    G Ital Dermatol Venereol; 1985; 120(4):297-306. PubMed ID: 3899920
    [No Abstract]   [Full Text] [Related]  

  • 11. Melan-A: not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis.
    El Shabrawi-Caelen L; Kerl H; Cerroni L
    Am J Dermatopathol; 2004 Oct; 26(5):364-6. PubMed ID: 15365366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accurate identification of proliferative index in melanocytic neoplasms with Melan-A/Ki-67 double stain.
    Puri PK; Valdes CL; Burchette JL; Grichnik JM; Turner JW; Selim MA
    J Cutan Pathol; 2010 Sep; 37(9):1010-2. PubMed ID: 20002650
    [No Abstract]   [Full Text] [Related]  

  • 13. Pagetoid melanocytes in nevi simulant of melanoma.
    Zioga A; Batistatou A
    Virchows Arch; 2008 Jan; 452(1):113-4. PubMed ID: 18026988
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma: higher diagnostic accuracy with Melan-A and MART-1 compared with S-100 protein and HMB-45.
    Shidham VB; Qi DY; Acker S; Kampalath B; Chang CC; George V; Komorowski R
    Am J Surg Pathol; 2001 Aug; 25(8):1039-46. PubMed ID: 11474288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of Conventional Melanocytic Markers in Malignant Melanoma and Lymph Node Metastasis; an Uncommon but Dangerous Pitfall.
    Chang O; Argenyi Z
    Am J Dermatopathol; 2017 Oct; 39(10):760-763. PubMed ID: 27759690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melan A (MART-1): a new monoclonal antibody for malignant melanoma diagnosis.
    Orchard GE
    Br J Biomed Sci; 1998 Mar; 55(1):8-9. PubMed ID: 9684410
    [No Abstract]   [Full Text] [Related]  

  • 17. HMB-45, S-100, NK1/C3, and MART-1 in metastatic melanoma.
    Zubovits J; Buzney E; Yu L; Duncan LM
    Hum Pathol; 2004 Feb; 35(2):217-23. PubMed ID: 14991540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Coincidence of balloon cell melanoma with balloon cells in a dermal nevus].
    Gregel C; Wolter M; Kaufmann R
    Pathologe; 1998 Feb; 19(2):151-3. PubMed ID: 9556801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meningeal melanocytoma with nevus fuscoceruleus ophthalmomaxillaris: report of a case].
    WU C; WANG H; SHI QL; MA HH; LU ZF
    Zhonghua Bing Li Xue Za Zhi; 2011 Mar; 40(3):194-5. PubMed ID: 21575395
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of Melan-A/MART-1 antigen as a prognostic factor in primary cutaneous melanoma.
    Berset M; Cerottini JP; Guggisberg D; Romero P; Burri F; Rimoldi D; Panizzon RG
    Int J Cancer; 2001 Jan; 95(1):73-7. PubMed ID: 11241315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.